Logically stemming from these points is the practical need to establish agency and oversight – both regulatory and nonregulatory – to manage how these objectives are achieved through consistent systems and controls. With this need in mind, the AMIA paper calls for creation of new bodies, groups, or departments that govern implementation and use of AI within an institution, as well as a system of oversight across institutions. It also calls for Adaptive CDS Centers of Excellence to develop, test, evaluate, and advance the use of safe, effective ML-driven applications in practice.
"This AMIA Board-approved position paper establishes a policy agenda for the safe, effective use of Adaptive CDS in the U.S. healthcare system – and it positions AMIA as the organization to lead this agenda's execution," said Dykes.
AMIA, the leading professional association for informatics professionals, is the center of action for 5,500 informatics professionals from more than 65 countries. As the voice of the nation's top biomedical and health informatics professionals, AMIA and its members play a leading role in assessing the effect of health innovations on health policy, and advancing the field of informatics. AMIA actively supports five domains in informatics: translational bioinformatics, clinical research informatics, clinical informatics, consumer health informatics, and public health informatics.
Back to HCB News
